ONKURE THERAPEUTICS, INC. (OKUR) Free cash flow 2020–2025
ONKURE THERAPEUTICS, INC. (OKUR) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$51.9MFY2025 · since FY2020: -$18.6M → -$51.9M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$51.9M | -1.4% |
| FY2024 | -$51.2M | -47.1% |
| FY2023 | -$34.8M | +27.1% |
| FY2022 | -$47.7M | -25.0% |
| FY2021 | -$38.2M | -105.7% |
| FY2020 | -$18.6M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice
More OKUR financial trends
OKUR RevenueOKUR Net incomeOKUR Net marginOKUR Gross profitOKUR Gross marginOKUR Operating incomeOKUR Operating marginOKUR Operating cash flowOKUR Capital expendituresOKUR Return on equityOKUR Stock buybacksOKUR Dividends paidOKUR Total assetsOKUR Total liabilitiesOKUR Shareholders’ equityOKUR overview →